Table 1.
Patient characteristics by whether opportunity for treatment intensification existed during the follow-up (N=3153)
| No blood pressure Opportunity N=1956 | At least one blood pressure opportunity N=1197 | |
|---|---|---|
| Sex Males (%) | 98.0 | 97.6 |
| Age, median (IQR) | 65.0 (58.0, 76.0) | 65.0 (58.0, 75.0) |
| < 65 years, (%) | 49.3 | 49.7 |
| 65 - 74 years, (%) | 22.3 | 24.1 |
| 75 + years, (%) | 28.4 | 26.2 |
| Race (%) | ||
| White | 65.0 | 58.5 |
| Black | 20.6 | 27.2 |
| Other | 6.9 | 7.3 |
| Missing race | 7.5 | 7.0 |
| NIH stroke scale (%) | ||
| 0-2 | 53.5 | 53.72 |
| 3-9 | 38.2 | 41.19 |
| 10 + | 8.3 | 5.10 |
| Current Smoker (%) | 37.3 | 37.0 |
| Charlson Score (mean ±SD) | 1 (0, 2) | 1 (1, 2) |
| Antihypertensives at discharge, median (IQR) | 2 (1, 3) | 2 (1, 3) |
| Antihypertensive Class (%) | ||
| None | 9.6 | 5.2 |
| ACE/ARB | 26.0 | 26.2 |
| Alpha-1 Antagonist | 3.8 | 3.1 |
| Beta Blocker | 22.8 | 22.4 |
| Calcium Channel Blocker | 12.0 | 14.6 |
| Loop Diuretics | 6.5 | 6.1 |
| Other antihypertensives | 9.3 | 10.1 |
| Other Diuretic | 10.1 | 12.2 |
| Discharged to home (%) | 68.6 | 69.8 |